Punit Dhillon

CIK: 0001425052

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (10.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (55.0%)

Compensation grants

Other (G, F, J, C, D, …)7 (35.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SKYE

Skye Bioscience, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

SKYE
Skye Bioscience, Inc.
Aug 7, 2026
Award(A)
Direct
1.1M shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
650K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
125K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
9K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
9K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
21.6K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
21.6K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
250K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
250K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
36K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
36K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
12.4K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
12.4K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
650K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
SKYE
Skye Bioscience, Inc.
Feb 6, 2026
Award(A)
Stock Option (Right to Buy)
Direct
280K shares-
SKYE
Skye Bioscience, Inc.
Feb 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
250K shares-
SKYE
Skye Bioscience, Inc.
Nov 18, 2024
Sale(S)
Direct
82.5K shares at avg. $4.99$412K
SKYE
Skye Bioscience, Inc.
Nov 15, 2024
Sale(S)
Direct
364 shares at avg. $5.55$2K
SKYE
Skye Bioscience, Inc.
Oct 28, 2024
Award(A)
Stock Option (Right to Buy)
Direct
650K shares-

		Type	Shares	Price		Ownership
Aug 7, 2026	SKYE Skye Bioscience, Inc.	Award(A)	1,090,000	-	$0	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	650,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	9,013	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	9,013	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	21,586	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	21,586	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	250,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	250,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	36,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	36,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	12,360	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	12,360	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	650,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Feb 6, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	280,000	-	-	Direct
Feb 24, 2025	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	250,000	-	-	Direct
Nov 18, 2024	SKYE Skye Bioscience, Inc.	Sale(S)	82,546	$4.99	$411,905	Direct
Nov 15, 2024	SKYE Skye Bioscience, Inc.	Sale(S)	364	$5.55	$2,020	Direct
Oct 28, 2024	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	650,000	-	-	Direct

1-20 of 20 transactions

About DHILLON PUNIT

DHILLON PUNIT (SEC CIK 0001425052) files insider reports with the SEC as Chief Executive Officer of Skye Bioscience, Inc. (SKYE).

Signal8 holds 6 ownership filings by DHILLON PUNIT, all Form 4s, filed between Oct 30, 2024 and Aug 7, 2026. Those filings report 20 transactions, from Oct 28, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DHILLON PUNIT's filings is in SAN DIEGO, CA.

Recent filings by DHILLON PUNIT

Aug 7, 2026: Grant or award of SKYE shares (Form 4, code A).
Mar 31, 2026: Grant or award of SKYE derivative securities (Form 4, code A).
Mar 31, 2026: Disposition to issuer transaction of SKYE derivative securities (Form 4, code D).
Mar 31, 2026: Grant or award of SKYE derivative securities (Form 4, code A).
Mar 31, 2026: Disposition to issuer transaction of SKYE derivative securities (Form 4, code D).

Other insiders filing for Skye Bioscience, Inc. (SKYE)

Schwab Andrew J., Director
5AM Partners VII, LLC, 10% Owner
Sharp John P, Chief Financial Officer
Smith Karen L., Director
Twitty Christopher, Chief Scientific Officer
Jenkins Annalisa, Director

How to read Form 4 transaction codes